Diseases, Conditions, Syndromes

Ebola vaccine tests hailed a success

Experts at St George's, University of London, have reported that an Ebola vaccine is safe for children as well as adults and produces an immune response.

Diseases, Conditions, Syndromes

Ebola detected in semen of survivors two years after infection

Ebola virus RNA can persist in the semen of survivors more than two years after the onset of infection researchers at the University of North Carolina at Chapel Hill have found. The research team, which included investigators ...

Diseases, Conditions, Syndromes

Cerebrospinal fluid of survivors of Ebola virus disease examined

A new research letter published by JAMA Neurology reports on examinations of cerebrospinal fluid collected from survivors of Ebola virus disease (EVD) to investigate potential Ebola virus persistence in the central nervous ...

Diseases, Conditions, Syndromes

Ebola vaccine developed in Canada shows promising results

A phase 1 randomized controlled trial has found an Ebola virus disease (EVD) vaccine, developed in Canada, was well-tolerated with no safety concerns, and high antibodies were present in participants 6 months after immunization. ...

Oncology & Cancer

Novel retinal lesion seen in some ebola survivors

(HealthDay)—A small percentage of Ebola virus disease (EVD) survivors have a novel retinal lesion, according to research published in the July issue of the U.S. Centers for Disease Control and Prevention's Emerging Infectious ...

Diseases, Conditions, Syndromes

WHO: 400 contacts being traced in Congo's Ebola outbreak

Health workers are monitoring more than 400 people amid an Ebola outbreak in a remote corner of Congo where already three deaths have been blamed on the virus, the World Health Organization said Thursday.

page 9 from 28